Neuropsychiatry examines the intricate relationship between the brain and psychiatric disorders, focusing on how neurological factors contribute to mental health conditions. By studying the brain’s structure, function, and biochemical processes, neuropsychiatry seeks to explain how diseases like Alzheimer’s, Parkinson’s, and multiple sclerosis can manifest with psychiatric symptoms such as mood swings, hallucinations, and cognitive decline. The field bridges psychiatry and neurology, offering a holistic approach to treating patients whose conditions involve both psychological and neurological components. Innovative approaches in neuropsychiatry, including neuroimaging and neurogenetics, are shedding light on the underlying mechanisms of psychiatric disorders, leading to more effective treatment strategies. This evolving field holds promise for improving outcomes for patients who suffer from disorders that were once considered solely psychiatric or neurological.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : ACE-dependent Alzheimer’s Disease (AD)
Sergei M Danilov, University of Illinois, United States
Title : Examining the effects of prenatal neurotoxin exposure on the development of the prefrontal cortex and its impact on executive functioning and attentional capacities in children
David Joseph Sperbeck, Private practice, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany